25/03/2022at 14:57

CHMP approves 5 new drugs in March

Five new treatments have received a positive opinion at the CHMP’s monthly meeting in March, while six new indication extensions have been recommended.

Photo: Piroschka Van De Wouw/Reuters/Ritzau Scanpix

by MIKKEL AABENHUS HEMMINGSEN, translated by daniel pedersen

A total sum of 25 drugs have been recommended for European use three months into 2022.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

Access all locked articles
Receive our daily newsletters
Access our app

Get full access for you and your coworkers

Start a free company trial today

CHMP approves 13 new drugs
For subscribers
Column: This is how the Danish Medicines Council should strengthen its application process
For subscribers
Orphazyme withdraws marketing application ahead of final vote
For subscribers

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Front page now

Michael Løvbjerg, CEO and co-founder of Lizn | Foto: Lizn / Pr

Hearing health

New hearing company 14 years in the making – "We expect to rise to the top"

Three hearing aid industry veterans have in secret founded a company, Lizn, while refining over many years a hearing device that is now ready to be launched.

For subscribers

Regulation

Another UK authority looking into Novo Nordisk's marketing violation

For subscribers

Pharma & biotech

Ascendis Pharma initiates long-term study of Skytrofa

For subscribers

Pharma & biotech

Roche and Eli Lilly to collaborate on early Alzheimer's detection test

For subscribers

Britt Meelby Jensen, CEO of Ambu | Foto: Ambu/pr

Medtech

Ambu CEO: Technology, scalability and partnerships will ensure growth

For subscribers

Medtech

Nordea finds new Ambu targets encouraging and trustworthy

Sandoz fights to keep name secret of CMO behind contaminated antibiotic

GMP experts question Sandoz’s refusal to name the European CMO responsible for the contamination of antibiotic Dicillin.

For subscribers

Hearing health

New hearing company 14 years in the making – "We expect to rise to the top"

Three hearing aid industry veterans have in secret founded a company, Lizn, while refining over many years a hearing device that is now ready to be launched.

For subscribers

Medtech

Nordea finds new Ambu targets encouraging and trustworthy

Having looked over the Danish medtech company’s pipeline, the bank sees ”an opportunity for a strong double-digit earnings growth in the medium to long term.”